Richard Carvajal, MD, discusses the importance of a multidisciplinary approach when monitoring patients for immunotherapy toxicities.
Richard Carvajal, MD
Advertisement
Articles by Richard Carvajal, MD
Richard Carvajal, MD, discusses how to make decisions regarding the dosing limits of immunotherapy agents.
Advertisement
Latest Updated Articles
Richard Carvajal on Immunotherapy DosingPublished: February 14th 2017 | Updated:
Richard Carvajal on Multidisciplinary Approach to Managing Immunotherapy ToxicitiesPublished: March 13th 2017 | Updated:
